2014年7月25日
PEGylated polymer micelles for anticancer drug delivery carrier
Colloid and Interface Science in Pharmaceutical Research and Development
- ,
- 開始ページ
- 285
- 終了ページ
- 298
- 記述言語
- 英語
- 掲載種別
- 論文集(書籍)内論文
- DOI
- 10.1016/B978-0-444-62614-1.00014-4
- 出版者・発行元
- Elsevier Inc.
In this chapter, we provide an overview of poly(ethylene glycol) (PEG)-tethered (PEGylated) polymer micelles and their application for anticancer drug delivery carrier. An amphiphilic block copolymer forms a core-shell type of polymeric micelle in aqueous media that can be utilised as a carrier for the delivery of hydrophobic drugs. The incorporation of anticancer drugs into the core of PEGylated polymer micelles increases the solubility, stability and circulation of the drugs. Recently, new types of polymeric micelles have been proposed, including micelles characterised by pH-triggered disintegration and formation of a polyion complex of hydrophilic block polymers. For example, pH-sensitive PEGylated polymer micelles can control drug release and have been shown to be an effective chemotherapy with enhanced therapeutic efficacy against cancer cells. Therefore, PEGylated polymer micelles should perform well as a carrier for anticancer drug delivery.
- ID情報
-
- DOI : 10.1016/B978-0-444-62614-1.00014-4
- SCOPUS ID : 84942604588